Last updated at 23 Feb 2025 05:09 AM
Director
DIN: 09308388
Famidanaj Perween is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at MUBIN PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09308388.Famidanaj Perween is currently involved in 2 different roles. Their most recent position is with MUBIN LABORATORIES PRIVATE LIMITED as a Director. The first company Famidanaj Perween was appointed to as a director was MUBIN PHARMACEUTICALS PRIVATE LIMITED. Famidanaj Perween is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Famidanaj Perween is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at MUBIN PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09308388.Famidanaj Perween is currently involved in 2 different roles. Their most recent position is with MUBIN LABORATORIES PRIVATE LIMITED as a Director. The first company Famidanaj Perween was appointed to as a director was MUBIN PHARMACEUTICALS PRIVATE LIMITED. Famidanaj Perween is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Female
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
10 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MUBIN PHARMACEUTICALS PRIVATE LIMITED | Director | 26-Nov-2021 |
| KINDMANS LABORATORIES LIMITED | Individual Promoter | 24-Jan-2022 |
| KINDMANS LABORATORIES LIMITED | Director | 24-Jan-2022 |
| MUBIN LABORATORIES PRIVATE LIMITED | Director | 22-Feb-2025 |